Affiliations 

  • 1 International Nosocomial Infection Control Consortium, Buenos Aires, Argentina. Electronic address: victor_rosenthal@inicc.org
  • 2 University of Wisconsin, Madison, WI
  • 3 Medanta The Medicity, New Delhi, India
  • 4 Ondokuz Mayis University, Samsun, Turkey
  • 5 Ministry of Health, Riyadh, Kingdom of Saudi Arabia
  • 6 Ministry of Health, City of Kuwait, Kuwait
  • 7 King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
  • 8 Zhongshan Hospital, Fudan University, Shanghai, China
  • 9 Universidad Nacional de Colombia, Clínica Universitaria Colombia, Bogotá, Colombia
  • 10 Hospital Sao Paulo, Sao Paulo, Brazil
  • 11 Thammasat University Hospital, Pratumthani, Thailand
  • 12 National Institute for Public Health of Kosova and Medical School, Prishtina University, Prishtina, Kosova
  • 13 Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
  • 14 The Indus Hospital, Karachi, Pakistan
  • 15 St Luke's Medical Center, Manila, Philippines
  • 16 Children Hospital Cairo University Abu el Reesh, Cairo, Egypt
  • 17 American University of Beirut Medical Center, Beirut, Lebanon
  • 18 Central State Hospital 1, Ulaanbaatar, Mongolia
  • 19 Wroclaw University Hospital, Wroclaw, Poland
  • 20 Hung Vuong Hospital, Ho Chi Minh, Vietnam
  • 21 Hospital Eugenio Espejo, Hospital de los Valles, Quito, Ecuador
  • 22 University Malaya Medical Centre, Kuala Lumpur, Malaysia
  • 23 Hospital Clínica Bíblica, San Jose, Costa Rica
  • 24 Hospital de Clínicas Caracas, Caracas, Venezuela
  • 25 Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
  • 26 Faculty of Health Central Military Hospital Ruzomberok, Catholic University in Ruzomberok, Ružomberok, Slovakia
  • 27 Privolzhskiy District Medical Center, Nizhniy Novgorod, Russia
  • 28 Dubai Hospital, Dubai, United Arab Emirates
  • 29 Hospital de especialidades del Instituto Hondureño de Seguridad Social, Tegucigalpa, Honduras
  • 30 Burhan Nalbantoğlu Devlet Hastanesi, Nicosia, Cyprus
  • 31 Special Hospital for Surgical Diseases Filip Vtori, Skopje, Macedonia
  • 32 Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania
  • 33 National University Hospital, Singapore, Republic of Singapore
  • 34 Jordan University Hospital, Amman, Jordan
  • 35 Ibn Sina, Rabat, Morocco
  • 36 Hospital Episcopal San Lucas Guayama, Guayama, Puerto Rico
  • 37 University of Medicine and Pharmacy "Victor Babes" Clinical County Hospital, Timisoara, Romania
  • 38 Hospital Universitario Gral. Calixto García, Havana, Cuba
  • 39 University Hospital "Queen Giovanna-ISUL", Sofia, Bulgaria
  • 40 Hôpital d'Enfants, Tunis, Tunisia
  • 41 Hospital Santo Tomás, Panama, Panama
  • 42 Caja de Salud de la Banca Privada Reg. La Paz, La Paz, Bolivia
  • 43 Institute for Mother Child Health Care "Vukan Čupić", Belgrade, Serbia
  • 44 Hospital Regional Salto, Salto, Uruguay
  • 45 Sotiria, Athens, Greece
  • 46 Hospital General de la Plaza de la Salud, Santo Domingo, Dominican Republic
  • 47 Royal Care International Hospital, Khartoum, Sudan
  • 48 Sri Jayewardenepura General Hospital, Nugegoda, Sri Lanka
  • 49 Hospital Nacional de Niños Benjamin Bloom, San Salvador, El Salvador
  • 50 Hospital Civil de Guadalajara Fray Antonio Alcalde, Unidad de Terapia Intensiva de Adultos, Guadalajara, Mexico
Am J Infect Control, 2014 09;42(9):942-56.
PMID: 25179325 DOI: 10.1016/j.ajic.2014.05.029

Abstract

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line-associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications